Indivior Pharmaceuticals Inc (INDV.L) LSE
Currency In GBp
- General
- Statistics
- Historical Data
- Profile
- Financials
Indivior Pharmaceuticals Inc
Address
10710 Midlothian Turnpike
North Chesterfield, VA 23235
United States of America (the)
Phone
804 379 1090
Website
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Employees
1030
First IPO Date
December 22, 2014
Key Executives
| Name | Title | Pay | Year Born |
| Joseph J. Ciaffoni | Chief Executive Officer & Director | 3,007 | 1971 |
| Mark Crossley | Chief Executive Officer & Executive Director | 1.76M | 1970 |
| Ryan Preblick | Chief Financial Officer | 576,527 | 1976 |
| Christian Heidbreder | Chief Scientific Officer | 0 | 1963 |
| Hillel West | Chief Manufacturing & Supply Officer | 0 | 1968 |
| Jason Thompson | Vice President of Investor Relations | 0 | N/A |
| Jeffrey W. Burris | Chief Legal Officer | 0 | 1972 |
| Richard Simkin | Chief Commercial Officer | 0 | 1971 |
| Vishal Kalia | Chief Strategy & Operating Officer | 0 | 1981 |
| Angela Colon-Mahoney | Chief Human Resources Officer | 0 | 1976 |
| Cynthia Cetani | Chief Integrity & Compliance Officer | 0 | 1966 |
Description
As a holding company, Indivior Pharmaceuticals Inc primarily focuses on the development, manufacturing, and distribution of buprenorphine-containing prescription drugs aimed at addressing opioid dependence. Key offerings in its product lineup include Suboxone Film, Suboxone Tablet, and Subutex Tablet. The company's operational footprint spans several geographical areas, namely the United States, the United Kingdom, and the 'Rest of World' segment. Indivior Pharmaceuticals Inc commenced operations on September 26, 2014, and its corporate base is situated in North Chesterfield, VA.
